Reference materials and certified reference materials for water and food microbiology

Summary The concept of Certified Reference Materials (CRMs) for the verification of the accuracy of analytical methods and the traceability of the results to a CRM, is well accepted in chemistry. The use of Reference Materials (RMs) for intra-laboratory quality control schemes or for round-robin and proficiency testing is well established and follows from certain norms (ISO 9000 and EN 45000 series). For microbiology such concepts have not been fully defined and RMs are only rarely used. CRMs do not exist. To fill this gap the Commission of the European Community, through the BCR programme, has launched projects in collaboration with the RIVM (National Institute of Public Health and Environmental Protection) in Bilthoven (NL). Following fundamental considerations and feasibility studies, several intercomparisons have been held using selected laboratories working with food or water microbiology. Various microbiological strains have been subject of studies: Salmonella typhimurium, Listeria monocytogenes, Bacillus cereus, Staphylococcus aureus for food, Escherichia coli, Enterococcus faecium, Enterobacter cloacae and Staphylococcus warneri for water. To produce materials for interlaboratory studies, a set of milk powders was prepared by spray-drying. Separate portions were contaminated with one of the strains mentioned. The materials were then encapsuled in gelatine. It has been demonstrated that if protected in milk powder matrices, bacteria maintain the ability to be revived, but do not multiply. The modes of evaluation of the results for homogeneity and stability differ from those commonly used in chemistry.     

Advances in microbiology EQA

External quality assessment for microbiology laboratories has seen many changes over the past ten years. EQA is much less focused on the pure analytic process of identifying single organisms submitted in an artificial medium. Samples are more realistic, and can be used to address clinical relevancy. Samples can be supplemented with a variety of non-traditional challenges to extend testing to include a wider range of the pre- and post-analytic aspects of the laboratory cycle. A look to the future sees a broad range of newer targets, with increasing interest in virology and point-of-care testing. Received: 13 April 2002 Accepted: 24 June 2002     

Measurement uncertainty in microbiology

Testing laboratories wishing to comply with the requirements of ISO/IEC 17025:1999 need to estimate uncertainty of measurement for their quantitative methods. Many microbiological laboratories have had procedures available for monitoring variability in duplicate results generated by laboratory analysts for some time. These procedures, however, do not necessarily include all possible contributions to uncertainty in the calculations. Procedures for estimating microbiological method uncertainty, based on the Poisson distribution, have been published but, at times, the procedures can either underestimate uncertainty or require laboratories to undertake considerable experimental studies and more complex statistical calculations. This paper proposes procedures for estimating uncertainty of measurement in microbiology, whereby routine laboratory quality control data can be analyzed with simple statistical equations. The approaches used in these procedures are also applied to published data and examples, demonstrating that essentially equivalent results can be obtained with these procedures.     

Proteomics in medical microbiology

The techniques of proteomics (high resolution two-dimensional electrophoresis and protein characterisation) are widely used for microbiological research to analyse global protein synthesis as an indicator of gene expression. The rapid progress in microbial proteomics has been achieved through the wide availability of whole genome sequences for a number of bacterial groups. Beyond providing a basic understanding of microbial gene expression, proteomics has also played a role in medical areas of microbiology. Progress has been made in the use of the techniques for investigating the epidemiology and taxonomy of human microbial pathogens, the identification of novel pathogenic mechanisms and the analysis of drug resistance. In each of these areas, proteomics has provided new insights that complement genomic-based investigations. This review describes the current progress in these research fields and highlights some of the technical challenges existing for the application of proteomics in medical microbiology. The latter concern the analysis of genetically heterogeneous bacterial populations and the integration of the proteomic and genomic data for these bacteria. The characterisation of the proteomes of bacterial pathogens growing in their natural hosts remains a future challenge.     

Millifluidic droplet analyser for microbiology

We present a novel millifluidic droplet analyser (MDA) for precisely monitoring the dynamics of microbial populations over multiple generations in numerous (≥10(3)) aqueous emulsion droplets (~100 nL). As a first application, we measure the growth rate of a bacterial strain and determine the minimal inhibitory concentration (MIC) for the antibiotic cefotaxime by incubating bacteria in a fine gradient of antibiotic concentrations. The detection of cell activity is based on the automated detection of an epifluorescent signal that allows the monitoring of microbial populations up to a size of ~10(6) cells. We believe that this device is helpful for the study of population dynamic consequences of microbe-environment interactions and of individual cell differences. Moreover, the fluidic machine may improve clinical tests, as it simplifies, automates and miniaturizes the screening of numerous microbial populations that grow and evolve in compartments with a finely tuned composition.